HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hannah M Mitchison Selected Research

Ciliary Motility Disorders (Primary Ciliary Dyskinesia)

10/2021Higher throughput drug screening for rare respiratory diseases: readthrough therapy in primary ciliary dyskinesia.
12/2018Mutations in Outer Dynein Arm Heavy Chain DNAH9 Cause Motile Cilia Defects and Situs Inversus.
1/2018DNAAF1 links heart laterality with the AAA+ ATPase RUVBL1 and ciliary intraflagellar transport.
1/2018High prevalence of CCDC103 p.His154Pro mutation causing primary ciliary dyskinesia disrupts protein oligomerisation and is associated with normal diagnostic investigations.
1/2018C11orf70 Mutations Disrupting the Intraflagellar Transport-Dependent Assembly of Multiple Axonemal Dyneins Cause Primary Ciliary Dyskinesia.
1/2017X-linked primary ciliary dyskinesia due to mutations in the cytoplasmic axonemal dynein assembly factor PIH1D3.
9/2014CCDC151 mutations cause primary ciliary dyskinesia by disruption of the outer dynein arm docking complex formation.
7/2014MCIDAS mutations result in a mucociliary clearance disorder with reduced generation of multiple motile cilia.
1/2014Combined exome and whole-genome sequencing identifies mutations in ARMC4 as a cause of primary ciliary dyskinesia with defects in the outer dynein arm.
8/2013Mutations in ZMYND10, a gene essential for proper axonemal assembly of inner and outer dynein arms in humans and flies, cause primary ciliary dyskinesia.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hannah M Mitchison Research Topics

Disease

17Ciliary Motility Disorders (Primary Ciliary Dyskinesia)
10/2021 - 08/2002
10Ciliopathies
01/2021 - 08/2013
8Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis)
03/2018 - 04/2002
4Situs Inversus
12/2018 - 08/2002
4Jeune syndrome
03/2015 - 05/2013
3Infertility (Sterility)
12/2018 - 01/2013
2Hydrocephalus (Hydrocephaly)
11/2019 - 03/2012
2Inborn Genetic Diseases (Disease, Hereditary)
01/2017 - 11/2013
1Respiratory Tract Diseases (Respiratory Tract Disease)
10/2021
1Male Infertility (Male Sterility)
12/2018
1Cerebellar Diseases (Cerebellar Syndrome)
03/2018
1Retinitis Pigmentosa (Pigmentary Retinopathy)
08/2015
1Mainzer-Saldino Disease
11/2013
1Polydactyly (Polydactylism)
05/2013
1Paralysis (Palsy)
05/2012
1Hypertrophy
03/2008
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2007

Drug/Important Bio-Agent (IBA)

13Dyneins (Dynein)IBA
12/2018 - 08/2002
11Proteins (Proteins, Gene)FDA Link
01/2018 - 08/2004
3Axonemal DyneinsIBA
01/2018 - 03/2012
3Retinaldehyde (Retinal)IBA
08/2015 - 04/2002
2Biological ProductsIBA
01/2019 - 01/2017
1Pharmaceutical PreparationsIBA
10/2021
1Forkhead Transcription Factors (Forkhead Box Proteins)IBA
11/2019
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
03/2018
1Glutamate Receptors (Glutamate Receptor)IBA
03/2018
1Proteasome Endopeptidase Complex (Proteasome)IBA
08/2015
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
08/2015
1UbiquitinIBA
08/2015
1RNA Precursors (Precursor, mRNA)IBA
08/2015
1Fenofibrate (CiL)FDA LinkGeneric
01/2015
1lipopigmentsIBA
11/2013
1CeroidIBA
11/2013
1ElementsIBA
08/2013
1EnzymesIBA
11/2008
1Mannose (D-Mannose)IBA
11/2008
1Ion Channels (Ion Channel)IBA
03/2008
1Biomarkers (Surrogate Marker)IBA
12/2007
1Lysosomal Membrane ProteinsIBA
12/2007
1Neurotransmitter Agents (Neurotransmitter)IBA
12/2005
1Peptides (Polypeptides)IBA
08/2004
1OligonucleotidesIBA
01/2003
1CarbohydratesIBA
04/2002

Therapy/Procedure

2Therapeutics
10/2021 - 01/2021